Latest press and releases on orthopaedic products, devices, implants and services.
A new paper published in the December 21, 2016 edition of The Journal of Bone and Joint Surgery tackles the issue of patient cost-sharing for total joint arthroplasty implants. The authors, all with the New York University Langone Orthopedic Surgery, discuss the ethics of having patients pay toward a pricier implant—one that would otherwise be nixed due to cost containment.
The global 3D printed medical devices market is expected to reach US$ 279.6 Mn in 2016, witnessing a year-on-year growth of 17.5%.
This press release was orginally distributed by SBWire
Valley Cottage, NY -- (SBWIRE) -- 12/29/2016 -- Future Market Insights delivers key insights on the global 3D printed medical devices market in a new publication titled "3D Printed Medical Devices Market: Global Industry Analysis and Opportunity Assessment, 2016 – 2026". The global 3D printed medical devices market was estimated to be US$ 238 Mn in 2015 and it has a wide scope of growth in the forecast period. The global 3D printed medical devices market can be broadly classified into six segments depending on the technology namely – stereolithography (SLA), selective layer sintering (SLS), digital light processing (DLP), fused deposition modelling (FDM), polyjet / inkjet 3D printing, and electronic beam melting (EBM) – each with different applications that are specific to orthopaedic, dental, and internal and external prosthetics.
cell growth platforms, screws, pins, rods, implants and other orthopaedic fixtures, stents, and lumen reconstruction devices, hernia repair, pelvic organ prolapse, drug eluting and drug delivery implants, among others. The company's NovoPore product is used as a dressing in negative pressure wound therapy.
A virtual reality headset is rapidly moving from a piece of technological novelty to becoming a valuable surgical tool. Orthopaedic surgeons have harnessed the power of Microsoft’s HoloLens to guide them during the messy and high risk field of spinal surgery. The work of two pioneering doctors from Brazil who are using the device to help with a common procedure called spinal fusion, where screws are used to fix parts of the spine, has been captured on video. Warning: contains footage of actual surgery. Dr Henrique Lampert, an orthopaedic spine surgeon working in Santa Catarina, Brazil, and Dr Bruno Gobbato have found the headset can guide them to place the pedicle screws far more precisely.
Moximed®, Inc. announced today that the first patient has been treated in an FDA-approved IDE study for its latest generation unicompartmental unloading implant, the Atlas System. The Atlas System builds on the company’s eight years of clinical success with joint unloading implants for medial knee osteoarthritis (OA).
“I’m pleased to treat the first patient in the Atlas IDE study. I see in my practice a tremendous number of younger, early OA patients who are seeking an alternative to arthroplasty that will allow them to maintain a highly active lifestyle,” noted Andreas Gomoll, M.D., Associate Professor of Orthopaedic Surgery at Harvard Medical School and Director of the Orthopaedic Program at the Brigham and Women’s Hospital Center for Regenerative Medicine.
Clinical and retrieval evidence for corrosion of spine implants
All prosthetic implants are subject to some degree of wear and corrosion in the body. Wear is a mechanical process resulting from changes in load distribution and micro-motion, while corrosion is an electrochemical process of metal degradation. Certain types of corrosion, such as fretting, occur when chemical and mechanical factors, including crevice and abrasive wear, act on the implant.
Both wear and corrosion result in debris release from the implants into the surrounding tissues and subsequently into the human circulation, and can manifest with local and systemic reactions which, over time, may demand revision of components.
Steve Austin, better known as the Six Million Dollar Man from the 1974 series of the same name, was on the brink of death after his spaceship crashed in the iconic TV show. A cutting-edge operation using bionic implants saved his life — and gave him bionic strength and artificially enhanced gifts.
The show had all the makings of a gripping superhero action series. But that reality — artificial organs and limbs, not bionic strength — is suddenly not as far-fetched as it sounds. Technology has come so far that it can now be harnessed to replicate body parts.
Anyone, anywhere can solve a problem or build a medical device that can cure diseases, says Vivek Wadhwa, a fellow at Stanford University’s Rock Center for Corporate Governance.
This article originally appeared in Kaiser Health News
They are a little-known presence in many operating rooms, offering technical expertise to surgeons installing new knees, implanting cardiac defibrillators or performing delicate spine surgery.
Often called device reps--or by the more cumbersome and less transparent moniker “healthcare industry representatives”--these salespeople are employed by the companies that make medical devices: Stryker, Johnson & Johnson and Medtronic, to name a few. Their presence in the OR, particularly common in orthopedics and neurosurgery, is part of the equipment packages that hospitals typically buy.
Many “people who don’t work in healthcare don’t realize that industry reps are sometimes in the OR,” said Josephine Wergin, a risk management analyst for the ECRI Institute, a Pennsylvania nonprofit that conducts research on medical subjects for the healthcare industry.
By Jof Enriquez
Follow me on Twitter @jofenriq
Medtronic has launched a new business unit that offers total joint replacement products and services – including a total knee arthroplasty solution – and will assist hospitals in managing a new bundled payment program implemented by the Centers for Medicare & Medicaid Services (CMS).
Implemented April 1, 2016, for 800 participating U.S. hospitals, the Comprehensive Care for Joint Replacement (CJR) model tests bundled payments and quality measurements for episodes of care associated with hip and knee replacements to encourage hospitals, physicians, and post-acute care providers to work together to improve the quality and coordination of care, from initial hospitalization through recovery.
BELGRADE, Mont., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Irix-C cervical cage for use with autograft and/or allograft and the expansion of the range of levels allowable from C3-T1 to C2-T1. Previously the device was cleared only for use with autogenous bone graft. This furthers Xtant Medical's goal of being a comprehensive supplier of products to spine surgeons.
Xtant Medical’s 3Demin and patented OsteoSponge technology are excellent allografts to use with Irix-C due to their ability to compress, fill and expand in the device’s graft chamber, allowing for ideal bone contact and fusion.
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
Improving orthopaedic care, education and research using Internet technologies